Infleqtion has reached a significant milestone in its Q4Bio project, successfully executing biomarker discovery algorithms using 12 logical qubits on its Sqale neutral-atom quantum computer. This achievement was made possible through a $2 million Phase III contract from Wellcome Leap and collaboration with academic partners at the University of Chicago and MIT. The Q4Bio project utilizes a hybrid quantum-classical workflow to identify high-impact biomarkers, demonstrating the potential of quantum computing in accelerating biomedical research. By leveraging 12 logical qubits, Infleqtion's Sqale computer has shown its capability to handle complex computations, paving the way for further advancements in biomarker discovery1. This breakthrough matters to practitioners because it highlights the growing role of quantum computing in biomedical research, enabling faster and more accurate identification of biomarkers, which can lead to breakthroughs in disease diagnosis and treatment.